Evidence map›Paper›PMID 28819922›Full record

Trial reportInternational journal of behavioral medicine2017

Therapeutic Alliance, Client Need for Approval, and Perfectionism as Differential Moderators of Response to eHealth and Traditionally Delivered Treatments for Comorbid Depression and Substance Use Problems.

Frances J Kay-Lambkin, Amanda L Baker, Kerrin Palazzi, Terry J Lewin, Brian J Kelly

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in International journal of behavioral medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 3 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 3 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Frances J Kay-LambkinNHMRC Centre for Research Excellence in Mental Health and Substance Use, Sydney, New South Wales, Australia. f.kaylambkin@unsw.edu.au.ORCID 0000-0002-4252-5572
Amanda L BakerNHMRC Centre for Research Excellence in Mental Health and Substance Use, Sydney, New South Wales, Australia.
Kerrin PalazziClinical Research Design, Information Technology, and Statistical Support, Hunter Medical Research Institute, Sydney, New South Wales, Australia.
Terry J LewinPriority Research Centre for Brain and Mental Health, University of Newcastle, Sydney, New South Wales, Australia.
Brian J KellySchool of Medicine and Public Health, University of Newcastle, Sydney, New South Wales, Australia.
UNSW Sydney · AUHunter Medical Research Institute · AUQueensland Centre for Mental Health Research · AUUniversity of Newcastle Australia · AU

Funding

Alcohol Education Rehabilitation Foundation AERFDOCS\2002\G0353National Health and Medical Research Council APP1110371
6 · The paper itself

Abstract

purposeThis study sought to undertake an exploratory analysis of the impact of therapeutic alliance and dysfunctional attitudes (perfectionism and need for approval) on outcomes for participants receiving therapist-delivered and eHealth interventions for comorbid depression and alcohol/cannabis use problems. These factors have been shown in previous research to moderate response to psychological treatment for depression and related disorders.

methodParticipants (N = 274) with concurrent depression and alcohol/cannabis misuse were randomized to 10 sessions of therapist-delivered cognitive behavior therapy/motivational interviewing (CBT/MI), computer-delivered CBT/MI with brief therapist assistance (SHADE CBT/MI), or supportive counseling (PCT). Follow-up occurred at 3, 6, and 12 months post-baseline. Exploratory moderator analyses examined changes in depression, alcohol use, and cannabis use over the 3-12-month follow-up timepoints, adjusting for baseline, as a function of treatment allocation, and the hypothesized moderators of therapeutic alliance, perfectionism, and need for approval.

resultsThe sample size and number of comparisons in the analysis mean that the results are considered preliminary and need replication in larger trials. The analysis revealed that "client initiative," a subscale of therapeutic alliance, moderated change in depression scores between 3- and 12-month follow-up for the PCT group, with higher scores associated with decreases in depression over time. Higher therapeutic "bond" early in treatment for SHADE CBT/MI participants was associated with reduced cannabis use over time. Participants with higher "perfectionism" scores at baseline who received therapist CBT/MI reported increases in depression over the follow-up period, but reductions in depression if they received SHADE CBT/MI. Therapist CBT/MI participants high on "need for approval" at baseline reported better alcohol use outcomes over time.

conclusionThe preliminary nature of these results do not justify firm conclusions. However, the specific variables of perfectionism, need for approval, and client initiative show promise as moderators of treatment efficacy for comorbid depression and alcohol/cannabis use problems. Further research is justified to determine whether these factors can assist in tailoring the modality and strategies offered in the delivery of psychotherapy to this population.

Indexed as

AdolescentAdultAgedAlcoholismCognitive Behavioral TherapyCounselingDepressionDiagnosis, Dual (Psychiatry)FemaleHumansMaleMiddle AgedMotivational InterviewingPerfectionismPsychotherapySubstance-Related DisordersAddictionComorbidityDepressioneHealthNeed for approvalPerfectionismTherapeutic alliance

Identifiers

PMID28819922
OpenAlexW2749477262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.